| John Calvin Ireland, DO | |
|
2000 Se Blue Pkwy, Suite 270 B, Lees Summit, MO 64063-1041 | |
| (816) 333-1919 | |
| (816) 333-2614 |
| Full Name | John Calvin Ireland |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 22 Years |
| Location | 2000 Se Blue Pkwy, Lees Summit, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467575241 | NPI | - | NPPES |
| 200613650A | Medicaid | KS | |
| 1467575241 | Medicaid | MO | |
| 200613650B | Medicaid | KS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 2004024406 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Luke's East Hospital | Lees summit, MO | Hospital |
| St Lukes Hospital Of Kansas City | Kansas city, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Saint Lukes Physician Group Inc | 3577476894 | 1070 |
| Saint Lukes Physician Group Inc | 3577476894 | 1070 |
News Archive
Idera Pharmaceuticals, Inc. presented data on the evaluation of a Toll-like receptor (TLR) antagonist in a preclinical hyperlipidemia model today at the Keystone Symposia conference "Advances in Molecular Mechanisms of Atherosclerosis" being held in Banff, Alberta, Canada. Idera's proprietary TLR antagonists have dual activity for both TLR7 and TLR9, and present a potentially innovative approach for the treatment of certain autoimmune diseases.
A research group led by Osaka University and Panasonic Corporation developed a method for making a prompt, exhaustive isolation of olfactory receptors (ORs) responding to the odorant of interest. This achievement will enable quick and easy exhaustive analysis of ORs responding to specific odorants, which previously required a great deal of time and effort. These results may be applied to biosensors capable of highly detecting only desired odorants.
Novozymes Biopharma has entered a new collaborative research agreement with one of the world's top vaccine companies. The partnership will enable the company to evaluate Novozymes Biopharma's modified recombinant human albumin (rAlbumin) Veltis technology, to assess the dosing and performance of a novel subunit antigen vaccine candidate.
Suicidal thoughts or attempts are associated with daily smoking in current smokers, but not former smokers, according to an article in Archives of General Psychiatry.
A recent editorial published in the Public Library of Science's Neglected Tropical Diseases called Chagas disease, a parasite which kills about 20,000 people a year, "the AIDS of the Americas." The disease can be transferred to a child from its mother or by blood transfusions. About 20 percent of those infected can develop life-threatening illness that includes enlarged hearts or intestines, and the drugs used today to treat the disease can take months to work.
› Verified 6 days ago
| Entity Name | Saint Lukes Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093263717 PECOS PAC ID: 3577476894 Enrollment ID: O20031111000818 |
News Archive
Idera Pharmaceuticals, Inc. presented data on the evaluation of a Toll-like receptor (TLR) antagonist in a preclinical hyperlipidemia model today at the Keystone Symposia conference "Advances in Molecular Mechanisms of Atherosclerosis" being held in Banff, Alberta, Canada. Idera's proprietary TLR antagonists have dual activity for both TLR7 and TLR9, and present a potentially innovative approach for the treatment of certain autoimmune diseases.
A research group led by Osaka University and Panasonic Corporation developed a method for making a prompt, exhaustive isolation of olfactory receptors (ORs) responding to the odorant of interest. This achievement will enable quick and easy exhaustive analysis of ORs responding to specific odorants, which previously required a great deal of time and effort. These results may be applied to biosensors capable of highly detecting only desired odorants.
Novozymes Biopharma has entered a new collaborative research agreement with one of the world's top vaccine companies. The partnership will enable the company to evaluate Novozymes Biopharma's modified recombinant human albumin (rAlbumin) Veltis technology, to assess the dosing and performance of a novel subunit antigen vaccine candidate.
Suicidal thoughts or attempts are associated with daily smoking in current smokers, but not former smokers, according to an article in Archives of General Psychiatry.
A recent editorial published in the Public Library of Science's Neglected Tropical Diseases called Chagas disease, a parasite which kills about 20,000 people a year, "the AIDS of the Americas." The disease can be transferred to a child from its mother or by blood transfusions. About 20 percent of those infected can develop life-threatening illness that includes enlarged hearts or intestines, and the drugs used today to treat the disease can take months to work.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John Calvin Ireland, DO 2000 Se Blue Pkwy, Suite 270 B, Lees Summit, MO 64063-1041 Ph: (816) 333-1919 | John Calvin Ireland, DO 2000 Se Blue Pkwy, Suite 270 B, Lees Summit, MO 64063-1041 Ph: (816) 333-1919 |
News Archive
Idera Pharmaceuticals, Inc. presented data on the evaluation of a Toll-like receptor (TLR) antagonist in a preclinical hyperlipidemia model today at the Keystone Symposia conference "Advances in Molecular Mechanisms of Atherosclerosis" being held in Banff, Alberta, Canada. Idera's proprietary TLR antagonists have dual activity for both TLR7 and TLR9, and present a potentially innovative approach for the treatment of certain autoimmune diseases.
A research group led by Osaka University and Panasonic Corporation developed a method for making a prompt, exhaustive isolation of olfactory receptors (ORs) responding to the odorant of interest. This achievement will enable quick and easy exhaustive analysis of ORs responding to specific odorants, which previously required a great deal of time and effort. These results may be applied to biosensors capable of highly detecting only desired odorants.
Novozymes Biopharma has entered a new collaborative research agreement with one of the world's top vaccine companies. The partnership will enable the company to evaluate Novozymes Biopharma's modified recombinant human albumin (rAlbumin) Veltis technology, to assess the dosing and performance of a novel subunit antigen vaccine candidate.
Suicidal thoughts or attempts are associated with daily smoking in current smokers, but not former smokers, according to an article in Archives of General Psychiatry.
A recent editorial published in the Public Library of Science's Neglected Tropical Diseases called Chagas disease, a parasite which kills about 20,000 people a year, "the AIDS of the Americas." The disease can be transferred to a child from its mother or by blood transfusions. About 20 percent of those infected can develop life-threatening illness that includes enlarged hearts or intestines, and the drugs used today to treat the disease can take months to work.
› Verified 6 days ago
Quintin Lee Cokingtin, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 290 Ne Tudor Rd, Metropolitan Pumonary And Hospital Medicine, Lees Summit, MO 64086 Phone: 816-478-4200 Fax: 816-875-2597 | |
Norin Ansari, MD, MPH Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 110 Ne Saint Lukes Blvd Ste 500, Lees Summit, MO 64086 Phone: 816-287-6060 | |
Scott E Eveloff, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3470 Ne Ralph Powell Rd, Suite B, Lees Summit, MO 64064 Phone: 913-498-3003 Fax: 913-341-5958 | |
Dr. Benjamin Richard Alsop, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 110 Ne Saint Lukes Blvd Ste 530, Lees Summit, MO 64086 Phone: 816-554-3838 Fax: 816-554-1634 | |
Dr. Susan Rosamond, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 777 Nw Blue Pkwy, Suite 3020, Lees Summit, MO 64086 Phone: 816-251-0575 Fax: 816-622-0028 | |
William N Brodine, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 3200 Ne Ralph Powell Rd, Lees Summit, MO 64064 Phone: 816-525-1600 | |
Usman Haleem, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 20 Ne Saint Lukes Blvd, Suite 200, Lees Summit, MO 64086 Phone: 816-347-5100 Fax: 816-347-5136 |